- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03817671
The Clinical Outcome of Ultra-low Oxygen Tension on Post Thawed Human Blastocyst
Study Overview
Detailed Description
In vitro, Embryo development depends on several factors as temperature, pH, and oxygen in the surrounding environment of the embryo. Impaired culture conditions are highly correlated with poor embryo development. Oxygen is a powerful regulator of embryo function , as it is responsible for cell respiration, energy production and rapid cell growth . Increased levels of oxygen is associated with an increase in the levels of ROS , which leads to unfavorable culture conditions, as it might affect the stability of cell membrane, DNA, and protein function .
In the female reproductive tract, oxygen concentration fluctuates between 2-8%, which is considered to be at its highest level in the fallopian tube, while the lowest level is in the uterus . Pre-implantation embryo crosses the uterotubal junction after the time of compaction on Day 3, where it is exposed to a shift in oxygen tension to 2%. This variation may have a role in the metabolic reactions of the embryo, and in its preparation for implantation process.
Some studies suggested that culturing embryos with oxygen tension below 5% may have an embryological advantage mimicking nature.
Embryological laboratories routinely use low Oxygen tension (5%). Our purpose is to investigate if ultra-low oxygen tension (2%) has an advantage over low oxygen tension (5%) for post thawed human embryo regarding clinical outcomes.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hosam Zaki, MSc, FRCOG
- Phone Number: 00201222150018
- Email: hosamz@tedata.net
Study Contact Backup
- Name: Salma El Tanbouly, BSc.
- Phone Number: 00201279655807
- Email: salmaeltanbouly@gmail.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Ganin Fertility Center
-
Contact:
- Hosam Zaki, MSc, FRCOG
- Phone Number: 00201222150018
- Email: hosamz@teadata.net.eg
-
Contact:
- Salma El Tanbouly, BSc
- Phone Number: 00201279655807
- Email: salmaeltanbouly@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Single or Multiple Embryo transfer embryo transfer. Female age 18-40. Embryo vitrified on day 5 or day 6 of insemination.
Exclusion Criteria:
Use of sperm donation. Use of Oocyte donation. Use of gestational carrier. Uterine congenital anomalies. Presence of any of the endometrial factors that affect embryo implantation such as hydrosalpings, adenomyosis or previously known uterine infection.
Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Control arm (5% O2)
After thawing, embryos will be cultured in 25 μl drop of pre-equilibrated dishes of media covered with a layer of oil for 1.5 hours at 5.7% CO2, 5% O2, and 89.3% N2 till embryo transfer
|
Culturing embryos in 5% O2 just after thawing and till embryo transfer
|
Experimental: Experimental arm (2%O2)
After thawing, embryos will be cultured in 25 μl drop of pre-equilibrated dishes of media covered with a layer of oil for 1.5 hours at 5.7% CO2, 2% O2, and 92.3% N2 till embryo transfer
|
Culturing embryos in 2% O2 just after thawing and till embryo transfer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Pregnancy rate
Time Frame: Time frame: 15 days following embryo transfer
|
Defined as the pregnancy that is confirmed by both high levels of hCG and ultrasound confirmation of a gestational sac or heartbeat
|
Time frame: 15 days following embryo transfer
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ongoing pregnancy rate
Time Frame: Time frame: 20 weeks of gestation
|
Defined as the proportion of pregnancies that had completed ≥20 weeks of gestation
|
Time frame: 20 weeks of gestation
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Hosam Zaki, MSc, FRCOG, Ganin Fertility Center, Cairo, Egypt.
- Principal Investigator: Salma El Tanbouly, BSc., Ganin Fertility Center, Cairo, Egypt.
- Principal Investigator: Abd El Ghafar Hussin, BSc., Ganin Fertility Center, Cairo, Egypt.
- Principal Investigator: Hanaa El Khedr, Ganin Fertility Center, Cairo, Egypt.
Publications and helpful links
General Publications
- Swain JE, Carrell D, Cobo A, Meseguer M, Rubio C, Smith GD. Optimizing the culture environment and embryo manipulation to help maintain embryo developmental potential. Fertil Steril. 2016 Mar;105(3):571-587. doi: 10.1016/j.fertnstert.2016.01.035. Epub 2016 Feb 3. Erratum In: Fertil Steril. 2016 May;105(5):1377.
- Gardner DK. The impact of physiological oxygen during culture, and vitrification for cryopreservation, on the outcome of extended culture in human IVF. Reprod Biomed Online. 2016 Feb;32(2):137-41. doi: 10.1016/j.rbmo.2015.11.008. Epub 2015 Nov 25.
- Morin SJ. Oxygen tension in embryo culture: does a shift to 2% O2 in extended culture represent the most physiologic system? J Assist Reprod Genet. 2017 Mar;34(3):309-314. doi: 10.1007/s10815-017-0880-z. Epub 2017 Feb 8.
- Oliveira JB. Does embryo culture at low oxygen tension improve ART outcomes? JBRA Assist Reprod. 2017 Feb 1;21(1):1. doi: 10.5935/1518-0557.20170001. No abstract available.
- Kaser DJ, Bogale B, Sarda V, Farland LV, Williams PL, Racowsky C. Randomized controlled trial of low (5%) versus ultralow (2%) oxygen for extended culture using bipronucleate and tripronucleate human preimplantation embryos. Fertil Steril. 2018 Jun;109(6):1030-1037.e2. doi: 10.1016/j.fertnstert.2018.02.119.
- Ng KYB, Mingels R, Morgan H, Macklon N, Cheong Y. In vivo oxygen, temperature and pH dynamics in the female reproductive tract and their importance in human conception: a systematic review. Hum Reprod Update. 2018 Jan 1;24(1):15-34. doi: 10.1093/humupd/dmx028.
- Yang Y, Xu Y, Ding C, Khoudja RY, Lin M, Awonuga AO, Dai J, Puscheck EE, Rappolee DA, Zhou C. Comparison of 2, 5, and 20 % O2 on the development of post-thaw human embryos. J Assist Reprod Genet. 2016 Jul;33(7):919-27. doi: 10.1007/s10815-016-0693-5. Epub 2016 Mar 23.
- Leese HJ. Human embryo culture: back to nature. J Assist Reprod Genet. 1998 Sep;15(8):466-8. doi: 10.1023/a:1022526219202. No abstract available.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- GFCST11991
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Embryo Development
-
University Medical Centre MariborCompletedEmbryonic Development | Embryo Morphokinetics | Embryo MorphometrySlovenia
-
University Hospital, GasthuisbergCompleted
-
Universitair Ziekenhuis BrusselRecruiting
-
University Hospital, GasthuisbergCompleted
-
University Medical Centre MariborSlovenian Research AgencyCompleted
-
Ibn Sina HospitalBanon IVF Center Assiut, EgyptCompletedIn Vitro Human Embryo DevelopmentEgypt
-
Centre for Endocrinology and Reproductive Medicine...UnknownInfertility | Embryo Development | IVFItaly
-
European HospitalUnknownEmbryo Development | Blastocyst | Culture Media | Poor Responder | Severe Male InfertilityItaly
-
University Hospital Virgen de las NievesJunta de AndalucíaCompletedPregnancy Rate | Single Embryo Transfer | Embryo Implantation, DelayedSpain
Clinical Trials on 5% O2
-
The University of Hong Kong-Shenzhen HospitalRecruiting
-
Assistance Publique - Hôpitaux de ParisCompletedHypoxia | Infertility | Embryo Culture
-
Liliana Berenice Ramírez DomínguezCompletedInfertility, Female | Infertility, MaleMexico
-
University Hospital, ToulouseRecruitingPneumonia | Pneumonia, Ventilator-Associated | Length of StayFrance
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityCompleted
-
Centre Hospitalier Universitaire Saint PierreCompletedBronchoscopy | O2-supplementationBelgium
-
University of ZurichCompleted
-
University of PadovaPerforma di Crocicchia SrlCompleted
-
Cuneyt M. AlperNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedMiddle Ear Gas ExchangeUnited States
-
Medical University of ViennaCompletedHIV Infections | Ocular Physiology | RetinaAustria